News
COVID-19: Calls to NYC crisis hotline soar
April 29, 2020
Inbound call volume has increased roughly 50% since the COVID-19 pandemic hit.
![1]()
News
Acetaminophen plus ibuprofen cut patient-controlled morphine after total hip arthroplasty
April 29, 2020
Is the perioperative/early postoperative use of acetaminophen-ibuprofen associated with less patient-controlled morphine administration after total hip arthroplasty?
![1]()
News
Volunteer surgeon describes working at a New York hospital
April 29, 2020
Arghavan Salles, MD, travels across the country to help fight the COVID-19 surge.
News
Large study of COVID-19 N.Y.C. hospital cases shows high mortality
April 29, 2020
The large patient sample reflects the diversity of the city and its environs. “It’s a large representative sample of very diverse patients ranging in age from zero (under a year) to 107, from all walks of life and socioeconomic levels.”
Article
Chest imaging guidelines released for pediatric COVID-19
April 29, 2020
The authors wrote the consensus statement to help clinicians evaluate children with potential COVID-19, interpret chest imaging findings, and determine the best treatment for these patients.
News
Hospitals update hydroxychloroquine protocols after FDA warning
April 29, 2020
Some hospitals changed their use of hydroxychloroquine for patients with COVID-19 long before the FDA’s recent warning about the drug’s risks.
![1]()
Opinion
Reproductive psychiatry during the COVID-19 pandemic
April 29, 2020
Maternal psychiatric well-being during pregnancy is a strong predictor of obstetrical and neonatal outcomes, and postpartum mental health.
![1]()
News
Contact tracing, isolation have impact, study shows
April 29, 2020
Comprehensive isolation and contact tracing in China led to faster confirmation of new COVID-19 cases and faster isolation after diagnosis.
![1]()
News
Acute kidney injury in children hospitalized with diarrheal illness in the U.S.
April 29, 2020
Diarrheal illness is the fourth leading cause of death for children younger than 5 years and the fifth leading cause of years of life lost globally.
News
SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit
April 29, 2020
Merck reports topline results from ertugliflozin’s FDA-mandated cardiovascular outcomes trial.
